Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Takeda reports MIP-1alpha/RANTES receptor antagonists

Sep. 11, 1997

Bayer discloses inhibitors of leukotriene synthesis

Sep. 10, 1997

Inflazyme contracts Inveresk Research for IND support

Sep. 9, 1997

Celltech prepares improved PDE IV inhibitors

Sep. 8, 1997

Licensing agreement signed for OxSODrol

Sep. 5, 1997

Merck's asthma treatment receives first approvals

Sep. 4, 1997

Celltech prepares PDE IV inhibitors

Sep. 4, 1997

Sepracor's levalbuterol NDA accepted by FDA

Sep. 4, 1997

LT antagonist/antihistamine combination highly effective against EAR/LAR

Sep. 3, 1997

ET antagonists for asthma

Sep. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...